Higher TRAF3IP3 expression correlated with improved OS at 80 months follow-up (Fig. 2A, p = 0.042) and better PFI (Fig. 2B, p = 0.003) in HCC patients. Here, TRAF3IP3 is linked to hepatocellular carcinoma.